Le mode conseil est activé Arrêter

Nevro, ordinary share
US64157F1030, NVRO

Ajouter une action à la Liste de suivi
Sélectionnez tout Réinitialiser tout
Nevro, pays — États-Unis
Aucunes données de trading
Représentation des données graphique | tableau
Source d'information - PJSC "MOEX". Toute autre diffusion des informations MOEX est interdite sans l'accord préalable de PJSC "MOEX".
Source d'information - PJSC "MOEX". Toute autre diffusion des informations MOEX est interdite sans l'accord préalable de PJSC "MOEX".
de
à
ADD-IN
Add-in Cbonds API
bond data api
Il faut s'enregistrer
Envoyer la demande d'accès accès
Plus de 2 500 éléments ont été trouvés, veuillez préciser votre demande
Pas de données sur la période choisie

Dernières cotations

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Émetteur

Profil
Nevro Corp., a medical device company, develops and commercializes a neuromodulation platform for the treatment of chronic pain in the United States, Europe, and Australia. It offers Senza system, a spinal cord stimulation system that delivers ...
Nevro Corp., a medical device company, develops and commercializes a neuromodulation platform for the treatment of chronic pain in the United States, Europe, and Australia. It offers Senza system, a spinal cord stimulation system that delivers its proprietary HF10 therapy. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.
Montrer tout Cacher
  • Emetteur
  • Nom complet de l'emprunteur / émetteur
    Nevro Corp.
  • Secteur (industrie)
    Equipement médical

Rapports IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Indicateurs

Actualités

21/02/2024 Nevro: Entry Into A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
21/02/2024 Nevro: Results Of Operations And Financial Condition, Financial Statements And Exhibits
06/01/2024 Nevro: Results Of Operations And Financial Condition, Costs Associated With Exit Or Disposal Activities, Financial Statements And Exhibits
30/11/2023 Nevro: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Creation Of A Direct Financial Obligation Or An Obligation Under An, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits
01/11/2023 Nevro: Results Of Operations And Financial Condition, Financial Statements And Exhibits
Toutes les actualités de l'organisation

Obligations nationales et internationales de l'émetteur

Détenteurs

Leaders de l'industrie

Vous devez vous inscrire pour y accéder.